Physician profile
Devon M Langston
NPI 1396493912
$1,616.72
in general payments reported to CMS, 2019-2025
10 companies · $856 in 2025
The $856 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $406 · 2024: $354 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $700.11 | 2023-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Advance Xp |
| Calyxo, INC. | $270.42 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $233.60 | 2023-2025 | Titan |
| Astellas Pharma US INC | $114.89 | 2025 | Padcev |
| Sumitomo Pharma America, INC. | $113.86 | 2023 | |
| Olympus America INC. | $89.24 | 2023 | Itind System |
| Progenics Pharmaceuticals, INC. | $25.93 | 2024 | |
| Medtronic, INC. | $25.00 | 2023 | Interstim |
| Tolmar, INC. | $21.97 | 2025 | Jatenzo, Eligard |
| Laborie Medical Technologies Corp. | $21.70 | 2024 | Urgent Pc Neuromodulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Langston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.